AbbVie Narrows Adjusted Profit Guidance
November 01 2019 - 10:05AM
Dow Jones News
By Dave Sebastian
AbbVie Inc. (ABBV) on Friday raised the lower end of its
full-year adjusted profit guidance as it reported
better-than-expected adjusted profit and sales.
The biopharmaceutical company narrowed its adjusted per-share
earnings guidance to between $8.90 and $8.92 from between $8.82 to
$8.92. The guidance excludes $3.82 a share of intangible asset
amortization expense and non-cash charges, the company said.
AbbVie lowered its per-share earnings guidance to between $5.08
and $5.10 from between $5.69 and $5.79. The metric includes a
non-cash charge related to the launch of the psoriasis treatment
Skyrizi.
Write to Dave Sebastian at dave.sebastian@wsj.com
(END) Dow Jones Newswires
November 01, 2019 09:50 ET (13:50 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Jun 2024 to Jul 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Jul 2023 to Jul 2024
